To be eligible for inclusion , participants had to have at least one measurable lesion by CT or MRI according to Response Evaluation Criteria In Solid Tumors ( RECIST ) ; Eastern Cooperative Oncology Group performance status 0-2 ; adequate bone marrow , liver , and renal function ; and serum thyroid-stimulating hormone concentration lower than 05 mIU/L .